An announcement from Tryptamine Therapeutics ( (AU:TYP) ) is now available. Tryptamine Therapeutics has successfully raised $6.1 million through the issuance of shares to accelerate the clinical ...

Transaction showcases Evotec's unique capability enabling customers to produce biologics faster and at lower costs through its continuous manufacturing technologyAccelerated implementation of strategy ...

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial ...

Advances 5x30 strategy by expanding pipeline with a highly complementary asset that has the potential to provide several days ...

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...

With a projected CAGR of 7.5% (2025–2035), China is emerging as one of the fastest-growing chicory markets. A surge in urban ...